11 August 2016 - Approval based on cardiovascular outcome clinical trial EMPA-REG OUTCOME, which demonstrated empagliflozin significantly reduced the incidence of ...
20 July 2016 - Janssen announced today that Invokamet, a twice daily fixed-dose therapy combining Invokana (canagliflozin) and metformin hydrochloride into ...